Goody Science and Technology（002694）株式概要グッディ科学技術有限公司は、中国でプラスチックパイプの研究、開発、生産、販売を行っている。 詳細002694 ファンダメンタル分析スノーフレーク・スコア評価2/6将来の成長0/6過去の実績0/6財務の健全性2/6配当金0/6リスク分析マイナスの株主資本 すべてのリスクチェックを見る002694 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair ValueCN¥Current PriceCN¥2.23156.3% 割高 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-576m2b2016201920222025202620282031Revenue CN¥421.4mEarnings CN¥39.0mAdvancedSet Fair ValueView all narrativesGoody Science and Technology Co., Ltd. 競合他社Yongyue Science&TechnologyLtdSymbol: SHSE:603879Market cap: CN¥1.6bChangzhou Tiansheng New Materials GroupSymbol: SZSE:300169Market cap: CN¥1.7bAnhui Huangshan CapsuleSymbol: SZSE:002817Market cap: CN¥1.8bJiangsu Huaxin New MaterialLtdSymbol: SZSE:300717Market cap: CN¥1.7b価格と性能株価の高値、安値、推移の概要Goody Science and Technology過去の株価現在の株価CN¥2.2352週高値CN¥5.2152週安値CN¥2.20ベータ0.0391ヶ月の変化-10.80%3ヶ月変化-21.20%1年変化-51.20%3年間の変化-59.23%5年間の変化-11.51%IPOからの変化-55.63%最新ニュースReported Earnings • Apr 29Full year 2025 earnings released: CN¥0.67 loss per share (vs CN¥0.21 loss in FY 2024)Full year 2025 results: CN¥0.67 loss per share (further deteriorated from CN¥0.21 loss in FY 2024). Revenue: CN¥890.6m (up 5.8% from FY 2024). Net loss: CN¥481.8m (loss widened 214% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.お知らせ • Apr 29Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2026Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Ezhou, Hubei ChinaNew Risk • Apr 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.お知らせ • Mar 31Goody Science and Technology Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Goody Science and Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026お知らせ • Dec 31Goody Science and Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Goody Science and Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026Reported Earnings • Oct 29Third quarter 2025 earnings released: CN¥0.012 loss per share (vs CN¥0.03 loss in 3Q 2024)Third quarter 2025 results: CN¥0.012 loss per share (improved from CN¥0.03 loss in 3Q 2024). Revenue: CN¥221.6m (flat on 3Q 2024). Net loss: CN¥8.77m (loss narrowed 59% from 3Q 2024). Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.最新情報をもっと見るRecent updatesReported Earnings • Apr 29Full year 2025 earnings released: CN¥0.67 loss per share (vs CN¥0.21 loss in FY 2024)Full year 2025 results: CN¥0.67 loss per share (further deteriorated from CN¥0.21 loss in FY 2024). Revenue: CN¥890.6m (up 5.8% from FY 2024). Net loss: CN¥481.8m (loss widened 214% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.お知らせ • Apr 29Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2026Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Ezhou, Hubei ChinaNew Risk • Apr 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.お知らせ • Mar 31Goody Science and Technology Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Goody Science and Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026お知らせ • Dec 31Goody Science and Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Goody Science and Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026Reported Earnings • Oct 29Third quarter 2025 earnings released: CN¥0.012 loss per share (vs CN¥0.03 loss in 3Q 2024)Third quarter 2025 results: CN¥0.012 loss per share (improved from CN¥0.03 loss in 3Q 2024). Revenue: CN¥221.6m (flat on 3Q 2024). Net loss: CN¥8.77m (loss narrowed 59% from 3Q 2024). Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.お知らせ • Sep 30Goody Science and Technology Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Goody Science and Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025お知らせ • Jul 02Goody Science and Technology Co., Ltd. to Report First Half, 2025 Results on Aug 28, 2025Goody Science and Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 28, 2025New Risk • May 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-CN¥226m free cash flow). Minor Risk Latest financial reports are more than 6 months old (reported September 2024 fiscal period end).お知らせ • Apr 29Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2025Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2025, at 14:30 China Standard Time.お知らせ • Mar 31Goody Science and Technology Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025Goody Science and Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025お知らせ • Dec 31Goody Science and Technology Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Goody Science and Technology Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025分析記事 • Dec 22Revenues Not Telling The Story For Goody Science and Technology Co., Ltd. (SZSE:002694)Goody Science and Technology Co., Ltd.'s ( SZSE:002694 ) price-to-sales (or "P/S") ratio of 4.4x may not look like an...分析記事 • Nov 25Goody Science and Technology (SZSE:002694) Has Debt But No Earnings; Should You Worry?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-CN¥226m free cash flow). Minor Risk Share price has been volatile over the past 3 months (10% average weekly change).New Risk • Oct 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥226m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. This is currently the only risk that has been identified for the company.お知らせ • Sep 30Goody Science and Technology Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Goody Science and Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024Reported Earnings • Aug 29Second quarter 2024 earnings released: CN¥0.03 loss per share (vs CN¥0.28 profit in 2Q 2023)Second quarter 2024 results: CN¥0.03 loss per share (down from CN¥0.28 profit in 2Q 2023). Revenue: CN¥237.6m (down 12% from 2Q 2023). Net loss: CN¥18.7m (down 113% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.Buy Or Sell Opportunity • Jul 02Now 25% overvaluedOver the last 90 days, the stock has fallen 23% to CN¥4.05. The fair value is estimated to be CN¥3.24, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 23% over the last 3 years. Meanwhile, the company has become profitable.お知らせ • Jun 29Goody Science and Technology Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024Goody Science and Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024Buy Or Sell Opportunity • Jun 18Now 22% overvaluedOver the last 90 days, the stock has fallen 28% to CN¥3.92. The fair value is estimated to be CN¥3.21, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 23% over the last 3 years. Meanwhile, the company has become profitable.Buy Or Sell Opportunity • Jun 07Now 22% overvaluedOver the last 90 days, the stock has fallen 28% to CN¥3.92. The fair value is estimated to be CN¥3.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 23% over the last 3 years. Meanwhile, the company has become profitable.分析記事 • Jun 07Subdued Growth No Barrier To Goody Science and Technology Co., Ltd.'s (SZSE:002694) PriceWhen close to half the companies in the Chemicals industry in China have price-to-sales ratios (or "P/S") below 1.9x...New Risk • May 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 37% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (30% increase in shares outstanding).分析記事 • May 02Why Goody Science and Technology's (SZSE:002694) Earnings Are Better Than They SeemShareholders appeared to be happy with Goody Science and Technology Co., Ltd.'s ( SZSE:002694 ) solid earnings report...お知らせ • Apr 28Goody Science and Technology Co., Ltd., Annual General Meeting, May 17, 2024Goody Science and Technology Co., Ltd., Annual General Meeting, May 17, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Ezhou, Hubei China Agenda: To consider 2023 work report of the board of directors; to consider 2023 work report of the supervisory committee; to consider 2023 annual report and its summary; to consider 2023 annual accounts report; to consider 2023 profit distribution plan; to consider Cash management with idle proprietary funds; to consider Cash management with temporarily idle raised funds; to consider 2024 remuneration (allowance) plan for directors, supervisors and senior management; to consider Amendments to the Company's articles of association; and to consider Amendments to the Company's internal systems.Reported Earnings • Apr 26Full year 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.24 loss in FY 2022)Full year 2023 results: EPS: CN¥0.16 (up from CN¥0.24 loss in FY 2022). Revenue: CN¥932.8m (down 12% from FY 2022). Net income: CN¥91.9m (up CN¥225.1m from FY 2022). Profit margin: 9.9% (up from net loss in FY 2022). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.お知らせ • Mar 30Goody Science and Technology Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Goody Science and Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to CN¥4.50, the stock trades at a trailing P/E ratio of 37.5x. Average trailing P/E is 26x in the Chemicals industry in China. Total returns to shareholders of 131% over the past three years.Valuation Update With 7 Day Price Move • Jan 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥5.16, the stock trades at a trailing P/E ratio of 43.1x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 139% over the past three years.お知らせ • Dec 29Goody Science and Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024Goody Science and Technology Co., Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024New Risk • Dec 02New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 38% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (25% accrual ratio). Minor Risks High level of debt (75% net debt to equity). Shareholders have been diluted in the past year (38% increase in shares outstanding).お知らせ • Nov 19Goody Science and Technology Co., Ltd. Announces Director and Supervisor ElectionsGoody Science and Technology Co., Ltd. held its 4th Extraordinary General Meeting of 2023 on 15 November 2023, during which the following proposal(s) was/were approved: Election of non-independent directors, cumulative voting system applicable: Su Xiaozhong, Song Suqin, Lin Kaizu, Ye Suling, Wu Zutong, Liao Hongzhan. Election of independent directors, cumulative voting system applicable: Jiang Hailong, Lin Daoyou, Lin Laisen. Election of shareholder supervisors, cumulative voting system applicable: Zhang Chenyi, Niu Muhua.Reported Earnings • Oct 27Third quarter 2023 earnings released: CN¥0.003 loss per share (vs CN¥0.055 loss in 3Q 2022)Third quarter 2023 results: CN¥0.003 loss per share (improved from CN¥0.055 loss in 3Q 2022). Revenue: CN¥231.9m (down 8.0% from 3Q 2022). Net loss: CN¥1.84m (loss narrowed 94% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.New Risk • Aug 30New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 77% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (77% net debt to equity). Share price has been volatile over the past 3 months (8.2% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (8.0% increase in shares outstanding).Reported Earnings • Aug 30Second quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.11 loss in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.11 loss in 2Q 2022). Revenue: CN¥269.4m (down 13% from 2Q 2022). Net income: CN¥148.7m (up CN¥203.2m from 2Q 2022). Profit margin: 55% (up from net loss in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.New Risk • Jul 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 50% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).Reported Earnings • Apr 22First quarter 2023 earnings released: CN¥0.02 loss per share (vs CN¥0.03 loss in 1Q 2022)First quarter 2023 results: CN¥0.02 loss per share (improved from CN¥0.03 loss in 1Q 2022). Revenue: CN¥184.5m (down 23% from 1Q 2022). Net loss: CN¥11.2m (loss narrowed 38% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Non-Independent Director Ling Zhang is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.Reported Earnings • Oct 28Third quarter 2022 earnings released: CN¥0.03 loss per share (vs CN¥0.032 loss in 3Q 2021)Third quarter 2022 results: CN¥0.03 loss per share (improved from CN¥0.032 loss in 3Q 2021). Revenue: CN¥277.2m (down 33% from 3Q 2021). Net loss: CN¥16.5m (loss narrowed 19% from 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 98 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 26Second quarter 2022 earnings released: CN¥0.11 loss per share (vs CN¥0.04 loss in 2Q 2021)Second quarter 2022 results: CN¥0.11 loss per share (down from CN¥0.04 loss in 2Q 2021). Revenue: CN¥311.2m (down 27% from 2Q 2021). Net loss: CN¥54.4m (loss widened 141% from 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance.Board Change • Apr 27High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Non-Independent Director Ling Zhang is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.お知らせ • Apr 24Goody Science&Technology Co.,Ltd, Annual General Meeting, May 13, 2022Goody Science&Technology Co.,Ltd, Annual General Meeting, May 13, 2022, at 14:00 China Standard Time. Agenda: To consider 2021 work report of the board of directors; to consider 2021 work report of the supervisory committee; to consider 2021 annual accounts; and to discuss other matters.お知らせ • Dec 30Goody Science&Technology Co.,Ltd announced that it expects to receive CNY 467.8 million in fundingGoody Science & Technology Co.,Ltd announced a private placement of common shares for gross proceeds of up to CNY 467,800,000 on December 29, 2021.Reported Earnings • Oct 23Third quarter 2021 earnings released: CN¥0.032 loss per share (vs CN¥0.02 loss in 3Q 2020)The company reported a soft third quarter result with increased losses and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: CN¥414.5m (up 9.5% from 3Q 2020). Net loss: CN¥20.3m (loss widened 79% from 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 50 percentage points per year, which is a significant difference in performance.Reported Earnings • Aug 26Second quarter 2021 earnings released: CN¥0.04 loss per share (vs CN¥0.027 profit in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2021 results: Revenue: CN¥425.9m (down 3.5% from 2Q 2020). Net loss: CN¥22.6m (down 267% from profit in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.Reported Earnings • May 03First quarter 2021 earnings released: CN¥0.05 loss per share (vs CN¥0.06 loss in 1Q 2020)The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2021 results: Revenue: CN¥283.0m (up 96% from 1Q 2020). Net loss: CN¥25.3m (loss narrowed 28% from 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance.Reported Earnings • Apr 17Full year 2020 earnings released: CN¥0.43 loss per share (vs CN¥0.02 profit in FY 2019)The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: CN¥1.44b (down 12% from FY 2019). Net loss: CN¥238.7m (down CN¥249.4m from profit in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance.お知らせ • Mar 09Goody Science&Technology Co.,Ltd to Report Fiscal Year 2020 Results on Apr 23, 2021Goody Science&Technology Co.,Ltd announced that they will report fiscal year 2020 results on Apr 23, 2021Is New 90 Day High Low • Feb 01New 90-day low: CN¥2.10The company is down 25% from its price of CN¥2.79 on 03 November 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.Is New 90 Day High Low • Jan 11New 90-day low: CN¥2.21The company is down 28% from its price of CN¥3.06 on 13 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.Is New 90 Day High Low • Dec 22New 90-day low: CN¥2.66The company is down 18% from its price of CN¥3.24 on 23 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.Is New 90 Day High Low • Oct 28New 90-day low: CN¥2.87The company is down 3.0% from its price of CN¥2.95 on 30 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period.お知らせ • Oct 20Goody Science&Technology Co.,Ltd to Report Q3, 2020 Results on Oct 27, 2020Goody Science&Technology Co.,Ltd announced that they will report Q3, 2020 results on Oct 27, 2020お知らせ • Jul 24Goody Science&Technology Co.,Ltd to Report First Half, 2020 Results on Aug 20, 2020Goody Science&Technology Co.,Ltd announced that they will report first half, 2020 results on Aug 20, 2020株主還元002694CN ChemicalsCN 市場7D-4.7%5.1%4.7%1Y-51.2%69.6%35.4%株主還元を見る業界別リターン: 002694過去 1 年間で69.6 % の収益を上げたCN Chemicals業界を下回りました。リターン対市場: 002694は、過去 1 年間で35.4 % のリターンを上げたCN市場を下回りました。価格変動Is 002694's price volatile compared to industry and market?002694 volatility002694 Average Weekly Movement7.5%Chemicals Industry Average Movement7.0%Market Average Movement6.7%10% most volatile stocks in CN Market10.6%10% least volatile stocks in CN Market4.4%安定した株価: 002694 、 CN市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: 002694の 週次ボラティリティ ( 7% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト19791,195Hao Daiwww.goody.com.cnグッディ科学技術有限公司は中国でプラスチックパイプの研究、開発、生産、販売を行っている。同社は、ポリ塩化ビニル、ポリエチレン、ポリプロピレンの各シリーズのパイプを提供しており、これらのパイプは、自治体やビルへの給水、排水、農業、都市下水、通信電力被覆、ガス送電、放射加熱、工業用流体輸送などの分野で使用されている。また、スポーツイベントに関連した文化観光事業にも携わっている。同社は1979年に設立され、中国の鄂州に本社を置いている。もっと見るGoody Science and Technology Co., Ltd. 基礎のまとめGoody Science and Technology の収益と売上を時価総額と比較するとどうか。002694 基礎統計学時価総額CN¥1.60b収益（TTM）-CN¥492.04m売上高(TTM)CN¥920.23m1.7xP/Sレシオ-3.3xPER（株価収益率002694 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計002694 損益計算書（TTM）収益CN¥920.23m売上原価CN¥797.95m売上総利益CN¥122.28mその他の費用CN¥614.32m収益-CN¥492.04m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-0.68グロス・マージン13.29%純利益率-53.47%有利子負債／自己資本比率-177.9%002694 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/20 03:06終値2026/06/18 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレークこのレポートを生成するために使用した分析モデルの詳細は、当社の Github ページ でご覧いただけます。また、レポートの使い方に関する ガイド や YouTube の チュートリアル もご用意しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Goody Science and Technology Co., Ltd. 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Yuebo LiIndustrial Securities Co. Ltd.
Reported Earnings • Apr 29Full year 2025 earnings released: CN¥0.67 loss per share (vs CN¥0.21 loss in FY 2024)Full year 2025 results: CN¥0.67 loss per share (further deteriorated from CN¥0.21 loss in FY 2024). Revenue: CN¥890.6m (up 5.8% from FY 2024). Net loss: CN¥481.8m (loss widened 214% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 29Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2026Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Ezhou, Hubei China
New Risk • Apr 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
お知らせ • Mar 31Goody Science and Technology Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Goody Science and Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026
お知らせ • Dec 31Goody Science and Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Goody Science and Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026
Reported Earnings • Oct 29Third quarter 2025 earnings released: CN¥0.012 loss per share (vs CN¥0.03 loss in 3Q 2024)Third quarter 2025 results: CN¥0.012 loss per share (improved from CN¥0.03 loss in 3Q 2024). Revenue: CN¥221.6m (flat on 3Q 2024). Net loss: CN¥8.77m (loss narrowed 59% from 3Q 2024). Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
Reported Earnings • Apr 29Full year 2025 earnings released: CN¥0.67 loss per share (vs CN¥0.21 loss in FY 2024)Full year 2025 results: CN¥0.67 loss per share (further deteriorated from CN¥0.21 loss in FY 2024). Revenue: CN¥890.6m (up 5.8% from FY 2024). Net loss: CN¥481.8m (loss widened 214% from FY 2024). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 57 percentage points per year, which is a significant difference in performance.
お知らせ • Apr 29Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2026Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2026, at 14:30 China Standard Time. Location: The Company's Meeting Room, Ezhou, Hubei China
New Risk • Apr 27New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 8.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. This is currently the only risk that has been identified for the company.
お知らせ • Mar 31Goody Science and Technology Co., Ltd. to Report Q1, 2026 Results on Apr 29, 2026Goody Science and Technology Co., Ltd. announced that they will report Q1, 2026 results on Apr 29, 2026
お知らせ • Dec 31Goody Science and Technology Co., Ltd. to Report Fiscal Year 2025 Results on Apr 29, 2026Goody Science and Technology Co., Ltd. announced that they will report fiscal year 2025 results on Apr 29, 2026
Reported Earnings • Oct 29Third quarter 2025 earnings released: CN¥0.012 loss per share (vs CN¥0.03 loss in 3Q 2024)Third quarter 2025 results: CN¥0.012 loss per share (improved from CN¥0.03 loss in 3Q 2024). Revenue: CN¥221.6m (flat on 3Q 2024). Net loss: CN¥8.77m (loss narrowed 59% from 3Q 2024). Over the last 3 years on average, earnings per share has remained flat but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
お知らせ • Sep 30Goody Science and Technology Co., Ltd. to Report Q3, 2025 Results on Oct 29, 2025Goody Science and Technology Co., Ltd. announced that they will report Q3, 2025 results on Oct 29, 2025
お知らせ • Jul 02Goody Science and Technology Co., Ltd. to Report First Half, 2025 Results on Aug 28, 2025Goody Science and Technology Co., Ltd. announced that they will report first half, 2025 results on Aug 28, 2025
New Risk • May 18New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-CN¥226m free cash flow). Minor Risk Latest financial reports are more than 6 months old (reported September 2024 fiscal period end).
お知らせ • Apr 29Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2025Goody Science and Technology Co., Ltd., Annual General Meeting, May 19, 2025, at 14:30 China Standard Time.
お知らせ • Mar 31Goody Science and Technology Co., Ltd. to Report Q1, 2025 Results on Apr 29, 2025Goody Science and Technology Co., Ltd. announced that they will report Q1, 2025 results on Apr 29, 2025
お知らせ • Dec 31Goody Science and Technology Co., Ltd. to Report Fiscal Year 2024 Results on Apr 29, 2025Goody Science and Technology Co., Ltd. announced that they will report fiscal year 2024 results on Apr 29, 2025
分析記事 • Dec 22Revenues Not Telling The Story For Goody Science and Technology Co., Ltd. (SZSE:002694)Goody Science and Technology Co., Ltd.'s ( SZSE:002694 ) price-to-sales (or "P/S") ratio of 4.4x may not look like an...
分析記事 • Nov 25Goody Science and Technology (SZSE:002694) Has Debt But No Earnings; Should You Worry?Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
New Risk • Nov 14New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 10% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Less than 1 year of cash runway based on free cash flow trend (-CN¥226m free cash flow). Minor Risk Share price has been volatile over the past 3 months (10% average weekly change).
New Risk • Oct 31New major risk - Financial positionThe company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CN¥226m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. This is currently the only risk that has been identified for the company.
お知らせ • Sep 30Goody Science and Technology Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024Goody Science and Technology Co., Ltd. announced that they will report Q3, 2024 results on Oct 31, 2024
Reported Earnings • Aug 29Second quarter 2024 earnings released: CN¥0.03 loss per share (vs CN¥0.28 profit in 2Q 2023)Second quarter 2024 results: CN¥0.03 loss per share (down from CN¥0.28 profit in 2Q 2023). Revenue: CN¥237.6m (down 12% from 2Q 2023). Net loss: CN¥18.7m (down 113% from profit in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 75% per year but the company’s share price has only increased by 3% per year, which means it is significantly lagging earnings growth.
Buy Or Sell Opportunity • Jul 02Now 25% overvaluedOver the last 90 days, the stock has fallen 23% to CN¥4.05. The fair value is estimated to be CN¥3.24, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 23% over the last 3 years. Meanwhile, the company has become profitable.
お知らせ • Jun 29Goody Science and Technology Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024Goody Science and Technology Co., Ltd. announced that they will report first half, 2024 results on Aug 29, 2024
Buy Or Sell Opportunity • Jun 18Now 22% overvaluedOver the last 90 days, the stock has fallen 28% to CN¥3.92. The fair value is estimated to be CN¥3.21, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 23% over the last 3 years. Meanwhile, the company has become profitable.
Buy Or Sell Opportunity • Jun 07Now 22% overvaluedOver the last 90 days, the stock has fallen 28% to CN¥3.92. The fair value is estimated to be CN¥3.20, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 23% over the last 3 years. Meanwhile, the company has become profitable.
分析記事 • Jun 07Subdued Growth No Barrier To Goody Science and Technology Co., Ltd.'s (SZSE:002694) PriceWhen close to half the companies in the Chemicals industry in China have price-to-sales ratios (or "P/S") below 1.9x...
New Risk • May 27New minor risk - Earnings qualityThe company has large one-off items impacting its financial results. One-off items were 37% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Minor Risks Large one-off items impacting financial results. Shareholders have been diluted in the past year (30% increase in shares outstanding).
分析記事 • May 02Why Goody Science and Technology's (SZSE:002694) Earnings Are Better Than They SeemShareholders appeared to be happy with Goody Science and Technology Co., Ltd.'s ( SZSE:002694 ) solid earnings report...
お知らせ • Apr 28Goody Science and Technology Co., Ltd., Annual General Meeting, May 17, 2024Goody Science and Technology Co., Ltd., Annual General Meeting, May 17, 2024, at 14:30 China Standard Time. Location: The Company's Meeting Room, Ezhou, Hubei China Agenda: To consider 2023 work report of the board of directors; to consider 2023 work report of the supervisory committee; to consider 2023 annual report and its summary; to consider 2023 annual accounts report; to consider 2023 profit distribution plan; to consider Cash management with idle proprietary funds; to consider Cash management with temporarily idle raised funds; to consider 2024 remuneration (allowance) plan for directors, supervisors and senior management; to consider Amendments to the Company's articles of association; and to consider Amendments to the Company's internal systems.
Reported Earnings • Apr 26Full year 2023 earnings released: EPS: CN¥0.16 (vs CN¥0.24 loss in FY 2022)Full year 2023 results: EPS: CN¥0.16 (up from CN¥0.24 loss in FY 2022). Revenue: CN¥932.8m (down 12% from FY 2022). Net income: CN¥91.9m (up CN¥225.1m from FY 2022). Profit margin: 9.9% (up from net loss in FY 2022). The move to profitability was driven by lower expenses. Over the last 3 years on average, earnings per share has increased by 47% per year but the company’s share price has only increased by 22% per year, which means it is significantly lagging earnings growth.
お知らせ • Mar 30Goody Science and Technology Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024Goody Science and Technology Co., Ltd. announced that they will report Q1, 2024 results on Apr 26, 2024
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment deteriorates as stock falls 22%After last week's 22% share price decline to CN¥4.50, the stock trades at a trailing P/E ratio of 37.5x. Average trailing P/E is 26x in the Chemicals industry in China. Total returns to shareholders of 131% over the past three years.
Valuation Update With 7 Day Price Move • Jan 22Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to CN¥5.16, the stock trades at a trailing P/E ratio of 43.1x. Average trailing P/E is 32x in the Chemicals industry in China. Total returns to shareholders of 139% over the past three years.
お知らせ • Dec 29Goody Science and Technology Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024Goody Science and Technology Co., Ltd. announced that they will report fiscal year 2023 results on Apr 26, 2024
New Risk • Dec 02New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 38% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (25% accrual ratio). Minor Risks High level of debt (75% net debt to equity). Shareholders have been diluted in the past year (38% increase in shares outstanding).
お知らせ • Nov 19Goody Science and Technology Co., Ltd. Announces Director and Supervisor ElectionsGoody Science and Technology Co., Ltd. held its 4th Extraordinary General Meeting of 2023 on 15 November 2023, during which the following proposal(s) was/were approved: Election of non-independent directors, cumulative voting system applicable: Su Xiaozhong, Song Suqin, Lin Kaizu, Ye Suling, Wu Zutong, Liao Hongzhan. Election of independent directors, cumulative voting system applicable: Jiang Hailong, Lin Daoyou, Lin Laisen. Election of shareholder supervisors, cumulative voting system applicable: Zhang Chenyi, Niu Muhua.
Reported Earnings • Oct 27Third quarter 2023 earnings released: CN¥0.003 loss per share (vs CN¥0.055 loss in 3Q 2022)Third quarter 2023 results: CN¥0.003 loss per share (improved from CN¥0.055 loss in 3Q 2022). Revenue: CN¥231.9m (down 8.0% from 3Q 2022). Net loss: CN¥1.84m (loss narrowed 94% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 19% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth.
New Risk • Aug 30New minor risk - Financial positionThe company has a high level of debt. Net debt to equity ratio: 77% This is considered a minor risk. Having a high level of debt increases the company's balance sheet risk. The company has a higher interest repayment burden, leading to the need to allocate a greater amount of its earnings towards servicing the debt, potentially limiting growth options or shareholder distributions. It can also increase the risk of bankruptcy if business conditions deteriorate enough that the company can no longer meet its debt obligations. Currently, the following risks have been identified for the company: Minor Risks High level of debt (77% net debt to equity). Share price has been volatile over the past 3 months (8.2% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (8.0% increase in shares outstanding).
Reported Earnings • Aug 30Second quarter 2023 earnings released: EPS: CN¥0.28 (vs CN¥0.11 loss in 2Q 2022)Second quarter 2023 results: EPS: CN¥0.28 (up from CN¥0.11 loss in 2Q 2022). Revenue: CN¥269.4m (down 13% from 2Q 2022). Net income: CN¥148.7m (up CN¥203.2m from 2Q 2022). Profit margin: 55% (up from net loss in 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 30% per year, which means it is well ahead of earnings.
New Risk • Jul 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Chinese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 50% per year over the past 5 years. Minor Risk Share price has been volatile over the past 3 months (7.1% average weekly change).
Reported Earnings • Apr 22First quarter 2023 earnings released: CN¥0.02 loss per share (vs CN¥0.03 loss in 1Q 2022)First quarter 2023 results: CN¥0.02 loss per share (improved from CN¥0.03 loss in 1Q 2022). Revenue: CN¥184.5m (down 23% from 1Q 2022). Net loss: CN¥11.2m (loss narrowed 38% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 19% per year, which means it is well ahead of earnings.
Board Change • Nov 16High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Non-Independent Director Ling Zhang is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
Reported Earnings • Oct 28Third quarter 2022 earnings released: CN¥0.03 loss per share (vs CN¥0.032 loss in 3Q 2021)Third quarter 2022 results: CN¥0.03 loss per share (improved from CN¥0.032 loss in 3Q 2021). Revenue: CN¥277.2m (down 33% from 3Q 2021). Net loss: CN¥16.5m (loss narrowed 19% from 3Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 98 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 26Second quarter 2022 earnings released: CN¥0.11 loss per share (vs CN¥0.04 loss in 2Q 2021)Second quarter 2022 results: CN¥0.11 loss per share (down from CN¥0.04 loss in 2Q 2021). Revenue: CN¥311.2m (down 27% from 2Q 2021). Net loss: CN¥54.4m (loss widened 141% from 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance.
Board Change • Apr 27High number of new and inexperienced directorsThere are 7 new directors who have joined the board in the last 3 years. The company's board is composed of: 7 new directors. 5 experienced directors. No highly experienced directors. Non-Independent Director Ling Zhang is the most experienced director on the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of board continuity. Lack of experienced directors.
お知らせ • Apr 24Goody Science&Technology Co.,Ltd, Annual General Meeting, May 13, 2022Goody Science&Technology Co.,Ltd, Annual General Meeting, May 13, 2022, at 14:00 China Standard Time. Agenda: To consider 2021 work report of the board of directors; to consider 2021 work report of the supervisory committee; to consider 2021 annual accounts; and to discuss other matters.
お知らせ • Dec 30Goody Science&Technology Co.,Ltd announced that it expects to receive CNY 467.8 million in fundingGoody Science & Technology Co.,Ltd announced a private placement of common shares for gross proceeds of up to CNY 467,800,000 on December 29, 2021.
Reported Earnings • Oct 23Third quarter 2021 earnings released: CN¥0.032 loss per share (vs CN¥0.02 loss in 3Q 2020)The company reported a soft third quarter result with increased losses and weaker control over costs, although revenues improved. Third quarter 2021 results: Revenue: CN¥414.5m (up 9.5% from 3Q 2020). Net loss: CN¥20.3m (loss widened 79% from 3Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 50 percentage points per year, which is a significant difference in performance.
Reported Earnings • Aug 26Second quarter 2021 earnings released: CN¥0.04 loss per share (vs CN¥0.027 profit in 2Q 2020)The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2021 results: Revenue: CN¥425.9m (down 3.5% from 2Q 2020). Net loss: CN¥22.6m (down 267% from profit in 2Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 59 percentage points per year, which is a significant difference in performance.
Reported Earnings • May 03First quarter 2021 earnings released: CN¥0.05 loss per share (vs CN¥0.06 loss in 1Q 2020)The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2021 results: Revenue: CN¥283.0m (up 96% from 1Q 2020). Net loss: CN¥25.3m (loss narrowed 28% from 1Q 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 44 percentage points per year, which is a significant difference in performance.
Reported Earnings • Apr 17Full year 2020 earnings released: CN¥0.43 loss per share (vs CN¥0.02 profit in FY 2019)The company reported a poor full year result with weaker earnings, revenues and control over costs. Full year 2020 results: Revenue: CN¥1.44b (down 12% from FY 2019). Net loss: CN¥238.7m (down CN¥249.4m from profit in FY 2019). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 42 percentage points per year, which is a significant difference in performance.
お知らせ • Mar 09Goody Science&Technology Co.,Ltd to Report Fiscal Year 2020 Results on Apr 23, 2021Goody Science&Technology Co.,Ltd announced that they will report fiscal year 2020 results on Apr 23, 2021
Is New 90 Day High Low • Feb 01New 90-day low: CN¥2.10The company is down 25% from its price of CN¥2.79 on 03 November 2020. The Chinese market is up 7.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 20% over the same period.
Is New 90 Day High Low • Jan 11New 90-day low: CN¥2.21The company is down 28% from its price of CN¥3.06 on 13 October 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 12% over the same period.
Is New 90 Day High Low • Dec 22New 90-day low: CN¥2.66The company is down 18% from its price of CN¥3.24 on 23 September 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 9.0% over the same period.
Is New 90 Day High Low • Oct 28New 90-day low: CN¥2.87The company is down 3.0% from its price of CN¥2.95 on 30 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 3.0% over the same period.
お知らせ • Oct 20Goody Science&Technology Co.,Ltd to Report Q3, 2020 Results on Oct 27, 2020Goody Science&Technology Co.,Ltd announced that they will report Q3, 2020 results on Oct 27, 2020
お知らせ • Jul 24Goody Science&Technology Co.,Ltd to Report First Half, 2020 Results on Aug 20, 2020Goody Science&Technology Co.,Ltd announced that they will report first half, 2020 results on Aug 20, 2020
